MedPath

Clinical study to find out the safety and efficacy of a polyherbal local anaesthetic parenteral formulatio

Phase 1
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2022/04/042091
Lead Sponsor
Pankajakasthuri Herbals India Pvt Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Healthy volunteers

Has a legally acceptable representative capable of under standing the informed consent documents and providing consent on the participants behalf

Normal laboratory values in CBC, LFT and RFT

Non smokers, non substance abusers, non alcoholic

Exclusion Criteria

1.Pregnant or breastfeeding women.

2.Body mass index superior to 35�kg/m2.

3.Allergy to any one of the ingredients in the formulation.

4.Uncontrolled hypertension/congenital heart problems.

5.Life-threatening comorbidities.

6.Adults legally protected (under judicial protection, guardianship or supervision) and persons deprived of their liberty.

7.Those who are taking regular medication

8.Any other chronic illness

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary out of the study is to assess the safety and efficacy on single-dose administration of polyherbal local anaesthetic formulation in healthy adults. <br/ ><br>The next objective is to assess the tolerability and safety profiles on single dose administration of polyherbal local anaesthetic in the test subjects <br/ ><br>Timepoint: During the therapy
Secondary Outcome Measures
NameTimeMethod
ï?¶Checking the Nociception, Touch and Pain sensation up to 60 minutes <br/ ><br>ï?¶To find out any other therapeutic properties like antiinflammatory activity. <br/ ><br>Timepoint: During therapy
© Copyright 2025. All Rights Reserved by MedPath